Coya Therapeutics宣布完成研究者发起的开放标签研究患者入组,该研究采用低剂量IL-2和CTLA4-Ig联合疗法治疗轻度至中度额颞叶痴呆患者

美股速递
Sep 29, 2025

Coya Therapeutics宣布完成研究者发起的开放标签研究患者入组,该研究采用低剂量IL-2和CTLA4-Ig联合疗法治疗轻度至中度额颞叶痴呆患者。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10